30 years of historical data (1996–2025) · Healthcare · Medical - Diagnostics & Research
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Waters Corporation trades at 33.0x earnings, roughly in line with its 5-year average of 32.6x, sitting at the 78th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 49%. On a free-cash-flow basis, the stock trades at 42.9x P/FCF, roughly in line with the 5-year average of 42.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $23.2B | $22.7B | $22.1B | $19.5B | $20.7B | $23.1B | $15.4B | $15.9B | $14.6B | $15.6B | $10.9B |
| Enterprise Value | $24.0B | $23.5B | $23.5B | $21.6B | $21.9B | $24.2B | $16.5B | $17.4B | $15.0B | $16.9B | $12.3B |
| P/E Ratio → | 33.03 | 35.30 | 34.64 | 30.37 | 29.21 | 33.36 | 29.60 | 26.89 | 24.66 | 772.76 | 20.97 |
| P/S Ratio | 7.32 | 7.16 | 7.47 | 6.60 | 6.95 | 8.30 | 6.53 | 6.62 | 6.05 | 6.74 | 5.05 |
| P/B Ratio | 8.29 | 8.85 | 12.08 | 16.96 | 40.97 | 62.88 | 66.52 | — | 9.34 | 6.97 | 4.75 |
| P/FCF | 42.92 | 42.01 | 35.65 | 44.13 | 48.27 | 39.92 | 24.98 | 33.23 | 30.71 | 25.65 | 20.49 |
| P/OCF | 35.50 | 34.75 | 28.99 | 32.37 | 33.79 | 30.93 | 19.53 | 24.77 | 24.22 | 22.32 | 17.39 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Waters Corporation's enterprise value stands at 21.8x EBITDA, roughly in line with its 5-year average of 22.7x. The Healthcare sector median is 14.2x, placing the stock at a 53% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.42 | 7.93 | 7.29 | 7.35 | 8.69 | 6.96 | 7.22 | 6.20 | 7.33 | 5.66 |
| EV / EBITDA | 21.82 | 21.37 | 23.05 | 21.92 | 21.77 | 25.40 | 21.35 | 21.34 | 17.68 | 22.04 | 17.00 |
| EV / EBIT | 26.86 | 29.17 | 27.79 | 25.82 | 24.64 | 28.45 | 24.94 | 23.89 | 20.52 | 24.25 | 19.01 |
| EV / FCF | — | 43.53 | 37.88 | 48.76 | 51.03 | 41.82 | 26.63 | 36.24 | 31.44 | 27.88 | 22.96 |
Margins and return-on-capital ratios measuring operating efficiency
Waters Corporation earns an operating margin of 28.2%. ROE of 29.3% indicates solid capital efficiency. ROIC of 20.3% represents excellent returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.8% | 57.8% | 59.4% | 59.6% | 58.0% | 58.5% | 57.4% | 58.0% | 59.0% | 59.0% | 58.9% |
| Operating Margin | 28.2% | 28.2% | 27.9% | 27.7% | 29.4% | 29.5% | 27.3% | 29.4% | 30.6% | 28.7% | 28.8% |
| Net Profit Margin | 20.3% | 20.3% | 21.6% | 21.7% | 23.8% | 24.9% | 22.1% | 24.6% | 24.5% | 0.9% | 24.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 29.3% | 29.3% | 42.8% | 77.6% | 162.3% | 231.1% | 6575.9% | 87.7% | 31.2% | 0.9% | 23.9% |
| ROA | 13.3% | 13.3% | 13.9% | 16.2% | 22.2% | 23.3% | 19.3% | 18.8% | 13.1% | 0.4% | 11.7% |
| ROIC | 20.3% | 20.3% | 19.4% | 25.1% | 41.5% | 45.4% | 39.2% | 33.8% | 20.1% | 13.8% | 13.7% |
| ROCE | 18.5% | 18.5% | 21.7% | 25.8% | 35.6% | 36.9% | 32.3% | 27.0% | 18.5% | 14.9% | 15.9% |
Solvency and debt-coverage ratios — lower is generally safer
Waters Corporation carries a Debt/EBITDA ratio of 1.3x, which is manageable (60% below the sector average of 3.2x). Net debt stands at $820M ($1.4B total debt minus $588M cash). Interest coverage of 15.9x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.55 | 0.55 | 0.93 | 2.12 | 3.30 | 4.36 | 6.26 | — | 0.73 | 0.89 | 0.79 |
| Debt / EBITDA | 1.28 | 1.28 | 1.67 | 2.48 | 1.66 | 1.68 | 1.88 | 2.18 | 1.35 | 2.60 | 2.53 |
| Net Debt / Equity | — | 0.32 | 0.75 | 1.78 | 2.34 | 2.99 | 4.38 | — | 0.22 | 0.61 | 0.57 |
| Net Debt / EBITDA | 0.75 | 0.75 | 1.35 | 2.08 | 1.18 | 1.15 | 1.32 | 1.77 | 0.42 | 1.76 | 1.83 |
| Debt / FCF | — | 1.52 | 2.22 | 4.63 | 2.76 | 1.90 | 1.64 | 3.00 | 0.74 | 2.23 | 2.47 |
| Interest Coverage | 15.87 | 15.87 | 9.42 | 8.45 | 18.17 | 18.94 | 13.45 | 14.93 | 15.02 | 12.28 | 14.36 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio has declined from 2.22x to 2.11x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | — | 2.11 | 2.22 | 2.24 | 2.39 | 1.74 | 2.22 | 5.93 | 7.04 | 6.99 |
| Quick Ratio | — | — | 1.51 | 1.57 | 1.66 | 1.87 | 1.36 | 1.68 | 5.28 | 6.60 | 6.48 |
| Cash Ratio | — | — | 0.41 | 0.50 | 0.61 | 0.84 | 0.55 | 0.57 | 3.87 | 5.60 | 5.41 |
| Asset Turnover | — | 0.62 | 0.65 | 0.64 | 0.91 | 0.90 | 0.83 | 0.94 | 0.65 | 0.43 | 0.46 |
| Inventory Turnover | 2.34 | 2.34 | 2.51 | 2.32 | 2.74 | 3.25 | 3.31 | 3.15 | 3.40 | 3.50 | 3.39 |
| Days Sales Outstanding | — | 95.58 | 90.48 | 86.69 | 88.78 | 80.27 | 88.47 | 89.14 | 85.72 | 84.38 | 82.41 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Waters Corporation returns 0.1% to shareholders annually primarily through share buybacks. The earnings yield of 3.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.0% | 2.8% | 2.9% | 3.3% | 3.4% | 3.0% | 3.4% | 3.7% | 4.1% | 0.1% | 4.8% |
| FCF Yield | 2.3% | 2.4% | 2.8% | 2.3% | 2.1% | 2.5% | 4.0% | 3.0% | 3.3% | 3.9% | 4.9% |
| Buyback Yield | 0.1% | 0.1% | 0.1% | 0.4% | 3.0% | 2.8% | 1.3% | 15.5% | 9.0% | 2.1% | 3.0% |
| Total Shareholder Yield | 0.1% | 0.1% | 0.1% | 0.4% | 3.0% | 2.8% | 1.3% | 15.5% | 9.0% | 2.1% | 3.0% |
| Shares Outstanding | — | $60M | $60M | $59M | $60M | $62M | $62M | $68M | $78M | $81M | $81M |
Compare WAT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $23B | 33.0 | 21.8 | 42.9 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 | |
| $36B | 27.8 | 21.2 | 31.2 | 52.4% | 21.3% | 20.6% | 13.5% | 1.9 | |
| $9B | -381.5 | 22.9 | 201.2 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 | |
| $30B | -536.2 | 157.0 | 154.9 | 54.9% | 13.4% | -4.4% | 6.0% | 2.8 | |
| $134M | -4.9 | — | — | 6.8% | -4.3% | — | — | — | |
| $173B | 26.2 | 18.7 | 27.4 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 | |
| $125B | 35.2 | 18.4 | 23.8 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 | |
| $7B | 153.5 | 54.7 | 79.3 | 47.1% | 8.1% | 2.4% | 2.2% | 5.0 | |
| $1B | -19.1 | 18.1 | 28.0 | 45.5% | -1.9% | -3.2% | -0.5% | 2.2 | |
| $5B | 32.1 | 14.4 | 23.8 | 35.5% | 12.7% | 11.3% | 14.7% | 0.8 | |
| $45B | 43.0 | 31.1 | 42.4 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Deep dive into WAT consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying WAT stock.
Waters Corporation's current P/E ratio is 33.0x. The historical average is 27.8x. This places it at the 78th percentile of its historical range.
Waters Corporation's current EV/EBITDA is 21.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 19.1x.
Waters Corporation's return on equity (ROE) is 29.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 47.8%.
Based on historical data, Waters Corporation is trading at a P/E of 33.0x. This is at the 78th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Waters Corporation has 57.8% gross margin and 28.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Waters Corporation's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.